Global Sphingosine-1-Receptor Modulators Drugs Industry Research Report, Growth Trends and Competitive Analysis 2020-2026
- BMR3856535
- 111 Pages
- May 2020
- Healthcare
Prior to COVID-19, the global market for Sphingosine-1-Receptor Modulators Drugs was anticipated to grow from US$ XX million in 2020 to US$ XX million by 2026; it is expected to grow at a CAGR of XX% during 2021–2026, whereas post-COVID-19 scenario, the market for Sphingosine-1-Receptor Modulators Drugs is projected to grow from US$ XX million in 2020 (a change by ~XX% compared to market estimated for 2020 before the outbreak of COVID-19) to US$ XX billion by 2026; it is expected to grow at a CAGR of XX% during 2021–2026. The solicitation of proposals by the governments and public–private companies across the world to mitigate the impact of the COVID-19 pandemic is the key factor propelling the growth of the Sphingosine-1-Receptor Modulators Drugs market.
In terms of production side, this report researches the Sphingosine-1-Receptor Modulators Drugs production capacity, value, ex-factory price, growth rate, market share by manufacturers, regions (or countries) and by Type.
In terms of consumption side, this report focuses on the consumption of Sphingosine-1-Receptor Modulators Drugs by regions (countries) and by Application.
The global Sphingosine-1-Receptor Modulators Drugs market is thoroughly, accurately, and comprehensively assessed in the report with a large focus on market dynamics, market competition, regional growth, segmental analysis, and key growth strategies. Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of production analysis, the authors of the report have provided reliable estimations and calculations for global revenue and volume by Type segment of the global Sphingosine-1-Receptor Modulators Drugs market. These figures have been provided in terms of both revenue and volume for the period 2015-2026. Additionally, the report provides accurate figures for production by region in terms of revenue as well as volume for the same period. The report also includes production capacity statistics for the same period.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 200 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Sphingosine-1-Receptor Modulators Drugs market in 2020. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyzes the impact of Coronavirus COVID-19 on the Sphingosine-1-Receptor Modulators Drugs industry.
Geographic Segmentation
The report offers exhaustive assessment of different region-wise Sphingosine-1-Receptor Modulators Drugs markets such as North America, Europe, China and Japan, etc. Key regions covered in the report are U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E
For the period 2015-2025, the report provides country-wise revenue and volume sales analysis and region-wise revenue and volume analysis of the global Sphingosine-1-Receptor Modulators Drugs market. For the period 2015-2020, it provides sales (consumption) analysis and forecast of different regional markets by each application as well as type segment in terms of volume.
Manufacturers
The report includes comprehensive company profiling of leading and emerging companies competing in the global Sphingosine-1-Receptor Modulators Drugs market. It provides a detailed list of players operating at a global level. The players have been listed according to the type of products they offer in the global Sphingosine-1-Receptor Modulators Drugs market and other factors. As part of the company profiling, the analysts authoring the report has provided the market entry year of each player considered for the research study. The report also offers extensive price, volume sales, and revenue analysis by the manufacturer at the global level for the period 2015-2020.
By Type and Application Segments
The report includes a detailed analysis of leading and type and application segments of the global Sphingosine-1-Receptor Modulators Drugs market. All of the segments covered in the report are broadly analyzed based on some deciding factors. The segmental analysis section of the report offers revenue sales analysis and forecast of the global Sphingosine-1-Receptor Modulators Drugs market by each type segment for the period 2015-2025. It also offers volume sales (consumption) analysis and forecast of the global Sphingosine-1-Receptor Modulators Drugs market by each type segment for the same period. Also, it provides volume sales (consumption) analysis and forecast of the global Sphingosine-1-Receptor Modulators Drugs market by each application segment for the same period.
This report includes the following manufacturers:
Novartis
Bristol-Myers Squibb
Johnson & Johnson
Arena Pharmaceuticals
Idorsia
Sun Pharma
Biocon
HEC Pharm Co. Limited
Market Segment by Type
Fingolimod
Siponimod
Ozanimod
Other
Market Segment by Application
Hospital
Clinic
Other
Research Methodology
To compile the detailed study of the global Sphingosine-1-Receptor Modulators Drugs market, a robust research methodology has been adopted that aids in determining the key insights and also evaluates the growth prospects of the Sphingosine-1-Receptor Modulators Drugs market. QY Research analysts have conducted in-depth primary and secondary research to obtain crucial insights into the Sphingosine-1-Receptor Modulators Drugs market. To carry out secondary research, the analysts have collected the information through company annual reports, journals, company press releases, and paid databases that were referred to gain and identify better opportunities in the global market.
1.1 Research Scope
1.2 Top Sphingosine-1-Receptor Modulators Drugs Manufacturers Covered: Ranking by Revenue
1.3 Market Segment by Type
1.3.1 Global Sphingosine-1-Receptor Modulators Drugs Market Size by Type: 2015 VS 2020 VS 2026 (US$ Million)
1.3.2 Fingolimod
1.3.3 Siponimod
1.3.4 Ozanimod
1.3.5 Other
1.4 Market Segment by Application
1.4.1 Global Sphingosine-1-Receptor Modulators Drugs Consumption by Application: 2015 VS 2020 VS 2026
1.4.2 Hospital
1.4.3 Clinic
1.4.4 Other
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.5.2 Covid-19 Impact: Commodity Prices Indices
1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 Study Objectives
1.7 Years Considered
2 Global Market Perspective
2.1 Global Sphingosine-1-Receptor Modulators Drugs Revenue (2015-2026)
2.1.1 Global Sphingosine-1-Receptor Modulators Drugs Revenue (2015-2026)
2.1.2 Global Sphingosine-1-Receptor Modulators Drugs Sales (2015-2026)
2.2 Covid-19 Impact on Global Sphingosine-1-Receptor Modulators Drugs Market Size across Key Geographies Worldwide: 2015 VS 2020 VS 2026
2.2.1 Global Sphingosine-1-Receptor Modulators Drugs Sales by Regions (2015-2020)
2.2.2 Global Sphingosine-1-Receptor Modulators Drugs Revenue by Regions (2015-2020)
2.3 Global Top Sphingosine-1-Receptor Modulators Drugs Regions (Countries) Ranking by Market Size
2.4 Sphingosine-1-Receptor Modulators Drugs Industry Trends
2.4.1 Covid-19 Impact: Sphingosine-1-Receptor Modulators Drugs Market Trends
2.4.2 Covid-19 Impact: Sphingosine-1-Receptor Modulators Drugs Market Drivers
2.4.3 Covid-19 Impact: Sphingosine-1-Receptor Modulators Drugs Market Challenges
2.4.4 Covid-19 Impact: Sphingosine-1-Receptor Modulators Drugs Market Restraints
2.4.5 Primary Interviews with Key Sphingosine-1-Receptor Modulators Drugs Players: Views for Future
3 Covid-19 Impact on Competitive Landscape by Manufacturers
3.1 Global Top Sphingosine-1-Receptor Modulators Drugs Manufacturers by Sales (2015-2020)
3.1.1 Global Sphingosine-1-Receptor Modulators Drugs Sales by Manufacturers (2015-2020)
3.1.2 Global Sphingosine-1-Receptor Modulators Drugs Sales Market Share by Manufacturers (2015-2020)
3.1.3 Global 5 and 10 Largest Manufacturers by Sphingosine-1-Receptor Modulators Drugs Sales in 2019
3.2 Global Top Manufacturers Sphingosine-1-Receptor Modulators Drugs by Revenue
3.2.1 Global Sphingosine-1-Receptor Modulators Drugs Revenue by Manufacturers (2015-2020)
3.2.2 Global Sphingosine-1-Receptor Modulators Drugs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Sphingosine-1-Receptor Modulators Drugs Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Sphingosine-1-Receptor Modulators Drugs as of 2019)
3.4 Global Sphingosine-1-Receptor Modulators Drugs Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Sphingosine-1-Receptor Modulators Drugs Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Sphingosine-1-Receptor Modulators Drugs Market
3.7 Key Manufacturers Sphingosine-1-Receptor Modulators Drugs Product Offered
3.8 Mergers & Acquisitions, Expansion Plans
4 Covid-19 Impact on Market Size by Type
4.1 Global Sphingosine-1-Receptor Modulators Drugs Historic Market Review by Type (2015-2020)
4.1.2 Global Sphingosine-1-Receptor Modulators Drugs Sales Market Share by Type (2015-2020)
4.1.3 Global Sphingosine-1-Receptor Modulators Drugs Revenue Market Share by Type (2015-2020)
4.1.4 Sphingosine-1-Receptor Modulators Drugs Price by Type (2015-2020)
4.1 Global Sphingosine-1-Receptor Modulators Drugs Market Estimates and Forecasts by Type (2021-2026)
4.2.2 Global Sphingosine-1-Receptor Modulators Drugs Sales Forecast by Type (2021-2026)
4.2.3 Global Sphingosine-1-Receptor Modulators Drugs Revenue Forecast by Type (2021-2026)
4.2.4 Sphingosine-1-Receptor Modulators Drugs Price Forecast by Type (2021-2026)
5 Covid-19 Impact on Global Sphingosine-1-Receptor Modulators Drugs Market Size by Application
5.1 Global Sphingosine-1-Receptor Modulators Drugs Historic Market Review by Application (2015-2020)
5.1.2 Global Sphingosine-1-Receptor Modulators Drugs Sales Market Share by Application (2015-2020)
5.1.3 Global Sphingosine-1-Receptor Modulators Drugs Revenue Market Share by Application (2015-2020)
5.1.4 Sphingosine-1-Receptor Modulators Drugs Price by Application (2015-2020)
5.2 Global Sphingosine-1-Receptor Modulators Drugs Market Estimates and Forecasts by Application (2021-2026)
5.2.2 Global Sphingosine-1-Receptor Modulators Drugs Sales Forecast by Application (2021-2026)
5.2.3 Global Sphingosine-1-Receptor Modulators Drugs Revenue Forecast by Application (2021-2026)
5.2.4 Sphingosine-1-Receptor Modulators Drugs Price Forecast by Application (2021-2026)
6 North America
6.1 North America Sphingosine-1-Receptor Modulators Drugs Breakdown Data by Company
6.2 North America Sphingosine-1-Receptor Modulators Drugs Breakdown Data by Type
6.3 North America Sphingosine-1-Receptor Modulators Drugs Breakdown Data by Application
6.4 North America Sphingosine-1-Receptor Modulators Drugs Breakdown Data by Countries
6.4.1 North America Sphingosine-1-Receptor Modulators Drugs Sales by Countries
6.4.2 North America Sphingosine-1-Receptor Modulators Drugs Revenue by Countries
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Sphingosine-1-Receptor Modulators Drugs Breakdown Data by Company
7.2 Europe Sphingosine-1-Receptor Modulators Drugs Breakdown Data by Type
7.3 Europe Sphingosine-1-Receptor Modulators Drugs Breakdown Data by Application
7.4 Europe Sphingosine-1-Receptor Modulators Drugs Breakdown Data by Countries
7.4.1 Europe Sphingosine-1-Receptor Modulators Drugs Sales by Countries
7.4.2 Europe Sphingosine-1-Receptor Modulators Drugs Revenue by Countries
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
8 Asia Pacific
8.1 Asia Pacific Sphingosine-1-Receptor Modulators Drugs Breakdown Data by Company
8.2 Asia Pacific Sphingosine-1-Receptor Modulators Drugs Breakdown Data by Type
8.3 Asia Pacific Sphingosine-1-Receptor Modulators Drugs Breakdown Data by Application
8.4 Asia Pacific Sphingosine-1-Receptor Modulators Drugs Breakdown Data by Regions
8.4.1 Asia Pacific Sphingosine-1-Receptor Modulators Drugs Sales by Regions
8.4.2 Asia Pacific Sphingosine-1-Receptor Modulators Drugs Revenue by Regions
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
8.4.12 Philippines
8.4.13 Vietnam
9 Latin America
9.1 Latin America Sphingosine-1-Receptor Modulators Drugs Breakdown Data by Company
9.2 Latin America Sphingosine-1-Receptor Modulators Drugs Breakdown Data by Type
9.3 Latin America Sphingosine-1-Receptor Modulators Drugs Breakdown Data by Application
9.4 Latin America Sphingosine-1-Receptor Modulators Drugs Breakdown Data by Countries
9.4.1 Latin America Sphingosine-1-Receptor Modulators Drugs Sales by Countries
9.4.2 Latin America Sphingosine-1-Receptor Modulators Drugs Revenue by Countries
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sphingosine-1-Receptor Modulators Drugs Breakdown Data by Type
10.2 Middle East and Africa Sphingosine-1-Receptor Modulators Drugs Breakdown Data by Application
10.3 Middle East and Africa Sphingosine-1-Receptor Modulators Drugs Breakdown Data by Countries
10.3.1 Middle East and Africa Sphingosine-1-Receptor Modulators Drugs Sales by Countries
10.3.2 Middle East and Africa Sphingosine-1-Receptor Modulators Drugs Revenue by Countries
10.3.3 Turkey
10.3.4 Saudi Arabia
10.3.5 U.A.E
11 Company Profiles
11.1 Novartis
11.1.1 Novartis Corporation Information
11.1.2 Novartis Business Overview and Total Revenue (2019 VS 2018)
11.1.3 Novartis Sphingosine-1-Receptor Modulators Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.1.4 Novartis Sphingosine-1-Receptor Modulators Drugs Products and Services
11.1.5 Novartis SWOT Analysis
11.1.6 Novartis Recent Developments and Reaction to Covid-19
11.2 Bristol-Myers Squibb
11.2.1 Bristol-Myers Squibb Corporation Information
11.2.2 Bristol-Myers Squibb Business Overview and Total Revenue (2019 VS 2018)
11.2.3 Bristol-Myers Squibb Sphingosine-1-Receptor Modulators Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.2.4 Bristol-Myers Squibb Sphingosine-1-Receptor Modulators Drugs Products and Services
11.2.5 Bristol-Myers Squibb SWOT Analysis
11.2.6 Bristol-Myers Squibb Recent Developments and Reaction to Covid-19
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Corporation Information
11.3.2 Johnson & Johnson Business Overview and Total Revenue (2019 VS 2018)
11.3.3 Johnson & Johnson Sphingosine-1-Receptor Modulators Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.3.4 Johnson & Johnson Sphingosine-1-Receptor Modulators Drugs Products and Services
11.3.5 Johnson & Johnson SWOT Analysis
11.3.6 Johnson & Johnson Recent Developments and Reaction to Covid-19
11.4 Arena Pharmaceuticals
11.4.1 Arena Pharmaceuticals Corporation Information
11.4.2 Arena Pharmaceuticals Business Overview and Total Revenue (2019 VS 2018)
11.4.3 Arena Pharmaceuticals Sphingosine-1-Receptor Modulators Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.4.4 Arena Pharmaceuticals Sphingosine-1-Receptor Modulators Drugs Products and Services
11.4.5 Arena Pharmaceuticals SWOT Analysis
11.4.6 Arena Pharmaceuticals Recent Developments and Reaction to Covid-19
11.5 Idorsia
11.5.1 Idorsia Corporation Information
11.5.2 Idorsia Business Overview and Total Revenue (2019 VS 2018)
11.5.3 Idorsia Sphingosine-1-Receptor Modulators Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.5.4 Idorsia Sphingosine-1-Receptor Modulators Drugs Products and Services
11.5.5 Idorsia SWOT Analysis
11.5.6 Idorsia Recent Developments and Reaction to Covid-19
11.6 Sun Pharma
11.6.1 Sun Pharma Corporation Information
11.6.2 Sun Pharma Business Overview and Total Revenue (2019 VS 2018)
11.6.3 Sun Pharma Sphingosine-1-Receptor Modulators Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.6.4 Sun Pharma Sphingosine-1-Receptor Modulators Drugs Products and Services
11.6.5 Sun Pharma SWOT Analysis
11.6.6 Sun Pharma Recent Developments and Reaction to Covid-19
11.7 Biocon
11.7.1 Biocon Corporation Information
11.7.2 Biocon Business Overview and Total Revenue (2019 VS 2018)
11.7.3 Biocon Sphingosine-1-Receptor Modulators Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.7.4 Biocon Sphingosine-1-Receptor Modulators Drugs Products and Services
11.7.5 Biocon SWOT Analysis
11.7.6 Biocon Recent Developments and Reaction to Covid-19
11.8 HEC Pharm Co. Limited
11.8.1 HEC Pharm Co. Limited Corporation Information
11.8.2 HEC Pharm Co. Limited Business Overview and Total Revenue (2019 VS 2018)
11.8.3 HEC Pharm Co. Limited Sphingosine-1-Receptor Modulators Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.8.4 HEC Pharm Co. Limited Sphingosine-1-Receptor Modulators Drugs Products and Services
11.8.5 HEC Pharm Co. Limited SWOT Analysis
11.8.6 HEC Pharm Co. Limited Recent Developments and Reaction to Covid-19
12 Covid-19 Impact on Value Chain and Sales Channels Analysis
12.1 Covid-19 Impact on Sphingosine-1-Receptor Modulators Drugs Value Chain Analysis
12.2 Sales Channels Analysis
12.2.1 Sphingosine-1-Receptor Modulators Drugs Sales Channels
12.2.2 Sphingosine-1-Receptor Modulators Drugs Distributors
12.3 Sphingosine-1-Receptor Modulators Drugs Customers
13 Estimates and Projections by Regions (2021-2026)
13.1 Global Sphingosine-1-Receptor Modulators Drugs Sales Forecast (2021-2026)
13.1.1 Global Sphingosine-1-Receptor Modulators Drugs Sales Forecast by Regions (2021-2026)
13.1.2 Global Sphingosine-1-Receptor Modulators Drugs Revenue Forecast by Regions (2021-2026)
13.2 North America Market Size Forecast (2021-2026)
13.2.1 North America Sphingosine-1-Receptor Modulators Drugs Sales Forecast (2021-2026)
13.2.2 North America Sphingosine-1-Receptor Modulators Drugs Revenue Forecast (2021-2026)
13.2.3 North America Sphingosine-1-Receptor Modulators Drugs Size Forecast by County (2021-2026)
13.3 Europe Market Size Forecast (2021-2026)
13.3.1 Europe Sphingosine-1-Receptor Modulators Drugs Sales Forecast (2021-2026)
13.3.2 Europe Sphingosine-1-Receptor Modulators Drugs Revenue Forecast (2021-2026)
13.3.3 Europe Sphingosine-1-Receptor Modulators Drugs Size Forecast by County (2021-2026)
13.4 Asia Pacific Market Size Forecast (2021-2026)
13.4.1 Asia Pacific Sphingosine-1-Receptor Modulators Drugs Sales Forecast (2021-2026)
13.4.2 Asia Pacific Sphingosine-1-Receptor Modulators Drugs Revenue Forecast (2021-2026)
13.4.3 Asia Pacific Sphingosine-1-Receptor Modulators Drugs Size Forecast by Region (2021-2026)
13.5 Latin America Market Size Forecast (2021-2026)
13.5.1 Latin America Sphingosine-1-Receptor Modulators Drugs Sales Forecast (2021-2026)
13.5.2 Latin America Sphingosine-1-Receptor Modulators Drugs Revenue Forecast (2021-2026)
13.5.3 Latin America Sphingosine-1-Receptor Modulators Drugs Size Forecast by County (2021-2026)
13.6 Middle East and Africa Market Forecast
13.6.1 Middle East and Africa Sphingosine-1-Receptor Modulators Drugs Sales Forecast (2021-2026)
13.6.2 Middle East and Africa Sphingosine-1-Receptor Modulators Drugs Revenue Forecast (2021-2026)
13.6.3 Middle East and Africa Sphingosine-1-Receptor Modulators Drugs Size Forecast by County (2021-2026)
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
Table 1. Sphingosine-1-Receptor Modulators Drugs Key Market Segments
Table 2. Ranking of Global Top Sphingosine-1-Receptor Modulators Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Sphingosine-1-Receptor Modulators Drugs Market Size Growth Rate by Type 2021-2026 (K Units) & (Million US$)
Table 4. Major Manufacturers of Fingolimod
Table 5. Major Manufacturers of Siponimod
Table 6. Major Manufacturers of Ozanimod
Table 7. Major Manufacturers of Other
Table 8. Global Sphingosine-1-Receptor Modulators Drugs Market Share by Application 2019-2025 (K Units)
Table 9. COVID-19 Impact Global Market: (Four Sphingosine-1-Receptor Modulators Drugs Market Size Forecast Scenarios)
Table 10. Opportunities and Trends for Sphingosine-1-Receptor Modulators Drugs Players in the COVID-19 Landscape
Table 11. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 12. Key Regions/Countries Measures against Covid-19 Impact
Table 13. Proposal for Sphingosine-1-Receptor Modulators Drugs Players to Combat Covid-19 Impact
Table 14. Global Sphingosine-1-Receptor Modulators Drugs Market Size by Regions 2015-2020 (K Units) & (Million US$)
Table 15. Global Sphingosine-1-Receptor Modulators Drugs Sales by Regions 2015-2020 (K Units)
Table 16. Global Sphingosine-1-Receptor Modulators Drugs Sales Market Share by Regions 2015-2020
Table 17. Global Sphingosine-1-Receptor Modulators Drugs Revenue by Regions 2015-2020 (Million US$)
Table 18. Global Sphingosine-1-Receptor Modulators Drugs Revenue Market Share by Regions 2015-2020
Table 19. Top Sphingosine-1-Receptor Modulators Drugs Regions (Countries) Ranking by Market Size (US$ Million) in 2019
Table 20. Market Top Trends
Table 21. Sphingosine-1-Receptor Modulators Drugs Key Drivers: Impact Analysis (2021-2026)
Table 22. Sphingosine-1-Receptor Modulators Drugs Key Challenges
Table 23. Main Points Interviewed from Key Sphingosine-1-Receptor Modulators Drugs Players: Views for Future
Table 24. Global Sphingosine-1-Receptor Modulators Drugs Sales by Manufacturers (2015-2020) (K Units)
Table 25. Global Sphingosine-1-Receptor Modulators Drugs Sales Share by Manufacturers (2015-2020)
Table 26. Sphingosine-1-Receptor Modulators Drugs Revenue by Manufacturers (2015-2020) (Million US$)
Table 27. Sphingosine-1-Receptor Modulators Drugs Revenue Share by Manufacturers (2015-2020)
Table 28. Global Sphingosine-1-Receptor Modulators Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 29. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Sphingosine-1-Receptor Modulators Drugs as of 2019)
Table 30. Key Manufacturers Sphingosine-1-Receptor Modulators Drugs Average Selling Price (ASP) (2015-2020) (US$/Unit)
Table 31. Key Manufacturers Sphingosine-1-Receptor Modulators Drugs Plants/Factories Distribution
Table 32. Key Manufacturers Sphingosine-1-Receptor Modulators Drugs Area Served
Table 33. Date of Key Manufacturers Enter into Sphingosine-1-Receptor Modulators Drugs Market
Table 34. Key Manufacturers Sphingosine-1-Receptor Modulators Drugs Product Type
Table 35. Mergers & Acquisitions, Expansion Plans
Table 36. Global Fingolimod Sales and Revenue (2015-2020) (K Units) & (Million US$)
Table 37. Global Siponimod Sales and Revenue (2015-2020) (K Units) & (Million US$)
Table 38. Global Ozanimod Sales ana Revenue (2015-2020) (K Units) & (Million US$)
Table 39. Global Other Sales ana Revenue (2015-2020) (K Units) & (Million US$)
Table 40. Global Sphingosine-1-Receptor Modulators Drugs Sales (K Units) by Type (2015-2020)
Table 41. Global Sphingosine-1-Receptor Modulators Drugs Sales Share by Type (2015-2020)
Table 42. Global Sphingosine-1-Receptor Modulators Drugs Revenue (US$ Million) Market Share by Type (2015-2020)
Table 43. Global Sphingosine-1-Receptor Modulators Drugs Price (K Units) by Type (2015-2020)
Table 44. Global Sphingosine-1-Receptor Modulators Drugs Sales (K Units) by Type (2021-2026)
Table 45. Global Sphingosine-1-Receptor Modulators Drugs Sales Share by Type (2021-2026)
Table 46. Global Sphingosine-1-Receptor Modulators Drugs Revenue (US$ Million) Market Share by Type (2021-2026)
Table 47. Global Sphingosine-1-Receptor Modulators Drugs Revenue Share by Type (2021-2026)
Table 48. Global Sphingosine-1-Receptor Modulators Drugs Price (K Units) by Type (2021-2026)
Table 49. Global Sphingosine-1-Receptor Modulators Drugs Sales (K Units) by Application (2015-2020)
Table 50. Global Sphingosine-1-Receptor Modulators Drugs Sales Share by Application (2015-2020)
Table 51. Global Sphingosine-1-Receptor Modulators Drugs Revenue (US$ Million) Market Share by Application (2015-2020)
Table 52. Global Sphingosine-1-Receptor Modulators Drugs Price by Application 2015-2020 (US$/Unit)
Table 53. Global Sphingosine-1-Receptor Modulators Drugs Sales by Application (2015-2020) (K Units)
Table 54. Global Sphingosine-1-Receptor Modulators Drugs Sales Share by Application (2015-2020)
Table 55. Global Sphingosine-1-Receptor Modulators Drugs Revenue (US$ Million) Market Share by Application (2021-2026)
Table 56. Global Sphingosine-1-Receptor Modulators Drugs Revenue Share by Application (2021-2026)
Table 57. Global Sphingosine-1-Receptor Modulators Drugs Price (K Units) by Application (2021-2026)
Table 58. North America Sphingosine-1-Receptor Modulators Drugs Sales by Company (2015-2020) (K Units)
Table 59. North America Sphingosine-1-Receptor Modulators Drugs Sales Market Share by Company (2015-2020)
Table 60. North America Sphingosine-1-Receptor Modulators Drugs Sales by Type (2015-2020) (K Units)
Table 61. North America Sphingosine-1-Receptor Modulators Drugs Sales Market Share by Type (2015-2020)
Table 62. North America Sphingosine-1-Receptor Modulators Drugs Sales by Application (2015-2020) (K Units)
Table 63. North America Sphingosine-1-Receptor Modulators Drugs Sales Market Share by Application (2015-2020)
Table 64. North America Sphingosine-1-Receptor Modulators Drugs Sales by Countries (2015-2020) (K Units)
Table 65. North America Sphingosine-1-Receptor Modulators Drugs Sales Market Share by Countries (2015-2020)
Table 66. North America Sphingosine-1-Receptor Modulators Drugs Revenue by Countries (2015-2020) (Million US$)
Table 67. North America Sphingosine-1-Receptor Modulators Drugs Revenue Market Share by Countries (2015-2020)
Table 68. Europe Sphingosine-1-Receptor Modulators Drugs Sales by Company (2015-2020) (K Units)
Table 69. Europe Sphingosine-1-Receptor Modulators Drugs Sales Market Share by Company (2015-2020)
Table 70. Europe Sphingosine-1-Receptor Modulators Drugs Sales by Type (2015-2020) (K Units)
Table 71. Europe Sphingosine-1-Receptor Modulators Drugs Sales Market Share by Type (2015-2020)
Table 72. Europe Sphingosine-1-Receptor Modulators Drugs Sales by Application (2015-2020) (K Units)
Table 73. Europe Sphingosine-1-Receptor Modulators Drugs Sales Market Share by Application (2015-2020)
Table 74. Europe Sphingosine-1-Receptor Modulators Drugs Sales by Countries (2015-2020) (K Units)
Table 75. Europe Sphingosine-1-Receptor Modulators Drugs Sales Market Share by Countries (2015-2020)
Table 76. Europe Sphingosine-1-Receptor Modulators Drugs Revenue by Countries (2015-2020) (Million US$)
Table 77. Europe Sphingosine-1-Receptor Modulators Drugs Revenue Market Share by Countries (2015-2020)
Table 78. Asia Pacific Sphingosine-1-Receptor Modulators Drugs Sales by Regions (2015-2020) (K Units)
Table 79. Asia Pacific Sphingosine-1-Receptor Modulators Drugs Sales Market Share by Regions (2015-2020)
Table 80. Asia Pacific Sphingosine-1-Receptor Modulators Drugs Sales by Type (2015-2020) (K Units)
Table 81. Asia Pacific Sphingosine-1-Receptor Modulators Drugs Sales Market Share by Type (2015-2020)
Table 82. Asia Pacific Sphingosine-1-Receptor Modulators Drugs Sales by Application (2015-2020) (K Units)
Table 83. Asia Pacific Sphingosine-1-Receptor Modulators Drugs Sales Market Share by Application (2015-2020)
Table 84. Asia Pacific Sphingosine-1-Receptor Modulators Drugs Sales by Countries (2015-2020) (K Units)
Table 85. Asia Pacific Sphingosine-1-Receptor Modulators Drugs Sales Market Share by Regions (2015-2020)
Table 86. Asia Pacific Sphingosine-1-Receptor Modulators Drugs Revenue by Regions (2015-2020) (Million US$)
Table 87. Asia Pacific Sphingosine-1-Receptor Modulators Drugs Revenue Market Share by Regions (2015-2020)
Table 88. Latin America Sphingosine-1-Receptor Modulators Drugs Sales by Company (2015-2020) (K Units)
Table 89. Latin America Sphingosine-1-Receptor Modulators Drugs Sales Market Share by Company (2015-2020)
Table 90. Latin America Sphingosine-1-Receptor Modulators Drugs Sales by Type (2015-2020) (K Units)
Table 91. Latin America Sphingosine-1-Receptor Modulators Drugs Sales Market Share by Type (2015-2020)
Table 92. Latin America Sphingosine-1-Receptor Modulators Drugs Sales by Application (2015-2020) (K Units)
Table 93. Latin America Sphingosine-1-Receptor Modulators Drugs Sales Market Share by Application (2015-2020)
Table 94. Latin America Sphingosine-1-Receptor Modulators Drugs Sales by Countries (2015-2020) (K Units)
Table 95. Latin America Sphingosine-1-Receptor Modulators Drugs Sales Market Share by Countries (2015-2020)
Table 96. Latin America Sphingosine-1-Receptor Modulators Drugs Revenue by Countries (2015-2020) (Million US$)
Table 97. Latin America Sphingosine-1-Receptor Modulators Drugs Revenue Market Share by Countries (2015-2020)
Table 98. Middle East and Africa Sphingosine-1-Receptor Modulators Drugs Sales by Type (2015-2020) (K Units)
Table 99. Middle East and Africa Sphingosine-1-Receptor Modulators Drugs Sales Market Share by Type (2015-2020)
Table 100. Middle East and Africa Sphingosine-1-Receptor Modulators Drugs Sales by Application (2015-2020) (K Units)
Table 101. Middle East and Africa Sphingosine-1-Receptor Modulators Drugs Sales Market Share by Application (2015-2020)
Table 102. Middle East and Africa Sphingosine-1-Receptor Modulators Drugs Sales by Countries (2015-2020) (K Units)
Table 103. Middle East and Africa Sphingosine-1-Receptor Modulators Drugs Sales Market Share by Countries (2015-2020)
Table 104. Middle East and Africa Sphingosine-1-Receptor Modulators Drugs Revenue by Countries (2015-2020) (Million US$)
Table 105. Middle East and Africa Sphingosine-1-Receptor Modulators Drugs Revenue Market Share by Countries (2015-2020)
Table 106. Novartis Company Details
Table 107. Novartis Description and Business Overview
Table 108. Novartis Sphingosine-1-Receptor Modulators Drugs Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 109. Novartis Sphingosine-1-Receptor Modulators Drugs Sales Growth Rate (2015-2020)
Table 110. Novartis Sphingosine-1-Receptor Modulators Drugs Sales Market Share in Global Market
Table 111. Novartis Recent Development
Table 112. Bristol-Myers Squibb Company Details
Table 113. Bristol-Myers Squibb Description and Business Overview
Table 114. Bristol-Myers Squibb Sphingosine-1-Receptor Modulators Drugs Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 115. Bristol-Myers Squibb Sphingosine-1-Receptor Modulators Drugs Sales Growth Rate (2015-2020)
Table 116. Bristol-Myers Squibb Sphingosine-1-Receptor Modulators Drugs Sales Market Share in Global Market
Table 117. Bristol-Myers Squibb Recent Development
Table 118. Johnson & Johnson Company Details
Table 119. Johnson & Johnson Description and Business Overview
Table 120. Johnson & Johnson Sphingosine-1-Receptor Modulators Drugs Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 121. Johnson & Johnson Sphingosine-1-Receptor Modulators Drugs Sales Growth Rate (2015-2020)
Table 122. Johnson & Johnson Sphingosine-1-Receptor Modulators Drugs Sales Market Share in Global Market
Table 123. Johnson & Johnson Recent Development
Table 124. Arena Pharmaceuticals Company Details
Table 125. Arena Pharmaceuticals Description and Business Overview
Table 126. Arena Pharmaceuticals Sphingosine-1-Receptor Modulators Drugs Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 127. Arena Pharmaceuticals Sphingosine-1-Receptor Modulators Drugs Sales Growth Rate (2015-2020)
Table 128. Arena Pharmaceuticals Sphingosine-1-Receptor Modulators Drugs Sales Market Share in Global Market
Table 129. Arena Pharmaceuticals Recent Development
Table 130. Idorsia Company Details
Table 131. Idorsia Description and Business Overview
Table 132. Idorsia Sphingosine-1-Receptor Modulators Drugs Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 133. Idorsia Sphingosine-1-Receptor Modulators Drugs Sales Growth Rate (2015-2020)
Table 134. Idorsia Sphingosine-1-Receptor Modulators Drugs Sales Market Share in Global Market
Table 135. Idorsia Recent Development
Table 136. Sun Pharma Company Details
Table 137. Sun Pharma Description and Business Overview
Table 138. Sun Pharma Sphingosine-1-Receptor Modulators Drugs Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 139. Sun Pharma Sphingosine-1-Receptor Modulators Drugs Sales Growth Rate (2015-2020)
Table 140. Sun Pharma Sphingosine-1-Receptor Modulators Drugs Sales Market Share in Global Market
Table 141. Sun Pharma Recent Development
Table 142. Biocon Company Details
Table 143. Biocon Description and Business Overview
Table 144. Biocon Sphingosine-1-Receptor Modulators Drugs Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 145. Biocon Sphingosine-1-Receptor Modulators Drugs Sales Growth Rate (2015-2020)
Table 146. Biocon Sphingosine-1-Receptor Modulators Drugs Sales Market Share in Global Market
Table 147. Biocon Recent Development
Table 148. HEC Pharm Co. Limited Company Details
Table 149. HEC Pharm Co. Limited Description and Business Overview
Table 150. HEC Pharm Co. Limited Sphingosine-1-Receptor Modulators Drugs Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 151. HEC Pharm Co. Limited Sphingosine-1-Receptor Modulators Drugs Sales Growth Rate (2015-2020)
Table 152. HEC Pharm Co. Limited Sphingosine-1-Receptor Modulators Drugs Sales Market Share in Global Market
Table 153. HEC Pharm Co. Limited Recent Development
Table 154. Sphingosine-1-Receptor Modulators Drugs Distributors List
Table 155. Sphingosine-1-Receptor Modulators Drugs Customers List
Table 156. Global Sphingosine-1-Receptor Modulators Drugs Sales Forecast 2021-2026 (K Units) & (Million US$)
Table 157. Global Sphingosine-1-Receptor Modulators Drugs Sales Forecast by Type 2021-2026 (K Units)
Table 158. Global Sphingosine-1-Receptor Modulators Drugs Sales Forecast by Application 2021-2026 (K Units)
Table 159. Global Sphingosine-1-Receptor Modulators Drugs Sales Forecast by Regions 2021-2026 (K Units)
Table 160. Global Sphingosine-1-Receptor Modulators Drugs Revenue Forecast by Regions 2021-2026 (Million US$)
Table 161. North America Sphingosine-1-Receptor Modulators Drugs Sales Forecast by Countries 2021-2026 (K Units)
Table 162. North America Sphingosine-1-Receptor Modulators Drugs Revenue Forecast by Countries 2021-2026
Table 163. Europe Sphingosine-1-Receptor Modulators Drugs Sales Forecast by Countries 2021-2026 (K Units)
Table 164. Europe Sphingosine-1-Receptor Modulators Drugs Revenue Market Share Forecast by Countries 2021-2026
Table 165. Asia Pacific Sphingosine-1-Receptor Modulators Drugs Sales Forecast by Regions 2021-2026 (K Units)
Table 166. Asia Pacific Sphingosine-1-Receptor Modulators Drugs Revenue Forecast by Regions 2021-2026 (Million US$)
Table 167. Latin America Sphingosine-1-Receptor Modulators Drugs Sales Forecast by Countries 2021-2026 (K Units)
Table 168. Latin America Sphingosine-1-Receptor Modulators Drugs Revenue Forecast by Countries 2021-2026 (Million US$)
Table 169. Middle East and Africa Sphingosine-1-Receptor Modulators Drugs Sales Forecast by Regions 2021-2026 (K Units)
Table 170. Middle East and Africa Sphingosine-1-Receptor Modulators Drugs Revenue Forecast by Regions 2021-2026 (Million US$)
Table 171. Research Programs/Design for This Report
Table 172. Key Data Information from Secondary Sources
Table 173. Key Data Information from Primary Sources
List of Figures
Figure 1. Sphingosine-1-Receptor Modulators Drugs Product Picture
Figure 2. Global Sphingosine-1-Receptor Modulators Drugs Sales Market Shar by Type 2015-2026
Figure 3. Fingolimod Figures
Figure 4. Siponimod Figures
Figure 5. Ozanimod Figures
Figure 6. Other Figures
Figure 7. Global Sphingosine-1-Receptor Modulators Drugs Sales Market Share by Application in 2019 & 2026
Figure 8. Hospital Use Case
Figure 9. Clinic Use Case
Figure 10. Other Use Case
Figure 11. Sphingosine-1-Receptor Modulators Drugs Report Years Considered
Figure 12. Global Sphingosine-1-Receptor Modulators Drugs Market Size 2015-2026 (Million US$)
Figure 13. Global Sphingosine-1-Receptor Modulators Drugs Sales 2015-2020 (K Units)
Figure 14. Global Sphingosine-1-Receptor Modulators Drugs Market Size Market Share by Regions 2015-2020
Figure 15. Global Sphingosine-1-Receptor Modulators Drugs Sales Market Share by Regions in 2019
Figure 16. Porter's Five Forces Analysis
Figure 17. Global Sphingosine-1-Receptor Modulators Drugs Sales Share by Manufacturers in 2019
Figure 18. The 5 and 10 Largest Manufacturers in the World: Market Share by Sphingosine-1-Receptor Modulators Drugs Sales in 2019
Figure 19. Sphingosine-1-Receptor Modulators Drugs Value Share by Manufacturers in 2019
Figure 20. Sphingosine-1-Receptor Modulators Drugs Revenue Share by Manufacturers In 2019
Figure 21. Sphingosine-1-Receptor Modulators Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 22. Global Sphingosine-1-Receptor Modulators Drugs Revenue Share by Type (2015-2020)
Figure 23. Global Sphingosine-1-Receptor Modulators Drugs Revenue Growth Rate by Type in 2015 & 2019
Figure 24. Global Sphingosine-1-Receptor Modulators Drugs Market Share by Price Range (2015-2020)
Figure 25. Global Sphingosine-1-Receptor Modulators Drugs Revenue Share by Application (2015-2020)
Figure 26. Global Sphingosine-1-Receptor Modulators Drugs Revenue Growth Rate by Application in 2015 & 2019
Figure 27. North America Sphingosine-1-Receptor Modulators Drugs Revenue Growth Rate 2015-2020 (Million US$)
Figure 28. U.S. Sphingosine-1-Receptor Modulators Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 29. Canada Sphingosine-1-Receptor Modulators Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 30. Europe Sphingosine-1-Receptor Modulators Drugs Revenue Growth Rate 2015-2020 (Million US$)
Figure 31. Germany Sphingosine-1-Receptor Modulators Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 32. France Sphingosine-1-Receptor Modulators Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 33. U.K. Sphingosine-1-Receptor Modulators Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 34. Italy Sphingosine-1-Receptor Modulators Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 35. Russia Sphingosine-1-Receptor Modulators Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 36. Asia Pacific Sphingosine-1-Receptor Modulators Drugs Revenue Growth Rate 2015-2020 (Million US$)
Figure 37. China Sphingosine-1-Receptor Modulators Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 38. Japan Sphingosine-1-Receptor Modulators Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 39. South Korea Sphingosine-1-Receptor Modulators Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 40. India Sphingosine-1-Receptor Modulators Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 41. Australia Sphingosine-1-Receptor Modulators Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 42. Taiwan Sphingosine-1-Receptor Modulators Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 43. Indonesia Sphingosine-1-Receptor Modulators Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 44. Thailand Sphingosine-1-Receptor Modulators Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 45. Malaysia Sphingosine-1-Receptor Modulators Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 46. Philippines Sphingosine-1-Receptor Modulators Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 47. Vietnam Sphingosine-1-Receptor Modulators Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 48. Latin America Sphingosine-1-Receptor Modulators Drugs Revenue Growth Rate 2015-2020 (Million US$)
Figure 49. Mexico Sphingosine-1-Receptor Modulators Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 50. Brazil Sphingosine-1-Receptor Modulators Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 51. Argentina Sphingosine-1-Receptor Modulators Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 52. Middle East and Africa Sphingosine-1-Receptor Modulators Drugs Revenue Growth Rate 2015-2020 (Million US$)
Figure 53. Turkey Sphingosine-1-Receptor Modulators Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 54. Saudi Arabia Sphingosine-1-Receptor Modulators Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 55. U.A.E Sphingosine-1-Receptor Modulators Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 56. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Bristol-Myers Squibb Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Arena Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. Idorsia Total Revenue (US$ Million): 2019 Compared with 2018
Figure 61. Sun Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 62. Biocon Total Revenue (US$ Million): 2019 Compared with 2018
Figure 63. HEC Pharm Co. Limited Total Revenue (US$ Million): 2019 Compared with 2018
Figure 64. Sphingosine-1-Receptor Modulators Drugs Value Chain
Figure 65. Channels of Distribution
Figure 66. Distributors Profiles
Figure 67. North America Sphingosine-1-Receptor Modulators Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 68. North America Sphingosine-1-Receptor Modulators Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 69. Europe Sphingosine-1-Receptor Modulators Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 70. Europe Sphingosine-1-Receptor Modulators Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 71. Asia Pacific Sphingosine-1-Receptor Modulators Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 72. Asia Pacific Sphingosine-1-Receptor Modulators Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 73. Latin America Sphingosine-1-Receptor Modulators Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 74. Latin America Sphingosine-1-Receptor Modulators Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 75. Middle East and Africa Sphingosine-1-Receptor Modulators Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 76. Middle East and Africa Sphingosine-1-Receptor Modulators Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 77. Bottom-up and Top-down Approaches for This Report
Figure 78. Data Triangulation
Figure 79. Key Executives Interviewed
Similar Reports
This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.
The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...
- Publish Date: March 2, 2020
- $0
Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...
- Publish Date: March 10, 2011
- $950
The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...
- Publish Date: July 18, 2011
- $950
